Literature DB >> 26240154

Delayed Hemolysis After Parenteral Artesunate Therapy for Severe Malaria in Two Returning Canadian Travelers.

Marthe Charles1, Jeffery M Patterson1, Leyla Asadi1, Stan Houston2.   

Abstract

Delayed hemolysis after parenteral artesunate has been described in Europe and Asia, but until recently had not been reported in patients receiving the artesunate product used in the United States and Canada. We report two cases of severe delayed hemolysis after the treatment with intravenous artesunate in Canada. © The American Society of Tropical Medicine and Hygiene.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26240154      PMCID： PMC4596605          DOI： 10.4269/ajtmh.15-0268

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN： 0002-9637            Impact factor:   2.345


  20 in total

Review 1.  Artemisinin-based combination therapies and their introduction in Japan.

Authors:  Shigeyuki Kano
Journal:  J Infect Chemother       Date:  2010-06-10       Impact factor: 2.211

2.  Severe malaria, artesunate and haemolysis.

Authors:  Pietro Caramello; Rosanna Balbiano; Tiziano De Blasi; Monica Chiriotto; Maura Deagostini; Guido Calleri
Journal:  J Antimicrob Chemother       Date:  2012-04-19       Impact factor: 5.790

3.  Haemolytic anaemia after oral artemether-lumefantrine treatment in a patient affected by severe imported falciparum malaria.

Authors:  P De Nardo; A Oliva; M L Giancola; P Ghirga; P Mencarini; M Bibas; E Nicastri; A Antinori; A Corpolongo
Journal:  Infection       Date:  2013-04-04       Impact factor: 3.553

4.  Delayed hemolysis after treatment with parenteral artesunate in African children with severe malaria--a double-center prospective study.

Authors:  Thierry Rolling; Tsiri Agbenyega; Saadou Issifou; Ayola Akim Adegnika; Justice Sylverken; Dorothee Spahlinger; Daniel Ansong; Sascha J Z Löhr; Gerd D Burchard; Jürgen May; Benjamin Mordmüller; Sanjeev Krishna; Peter G Kremsner; Jakob P Cramer
Journal:  J Infect Dis       Date:  2013-12-26       Impact factor: 5.226

5.  Post-treatment haemolysis in severe imported malaria after intravenous artesunate: case report of three patients with hyperparasitaemia.

Authors:  Thierry Rolling; Stefan Schmiedel; Dominic Wichmann; Dieter Wittkopf; Gerd-Dieter Burchard; Jakob P Cramer
Journal:  Malar J       Date:  2012-05-17       Impact factor: 2.979

6.  Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trial.

Authors:  Arjen M Dondorp; Caterina I Fanello; Ilse C E Hendriksen; Ermelinda Gomes; Amir Seni; Kajal D Chhaganlal; Kalifa Bojang; Rasaq Olaosebikan; Nkechinyere Anunobi; Kathryn Maitland; Esther Kivaya; Tsiri Agbenyega; Samuel Blay Nguah; Jennifer Evans; Samwel Gesase; Catherine Kahabuka; George Mtove; Behzad Nadjm; Jacqueline Deen; Juliet Mwanga-Amumpaire; Margaret Nansumba; Corine Karema; Noella Umulisa; Aline Uwimana; Olugbenga A Mokuolu; Olanrewaju T Adedoyin; Wahab B R Johnson; Antoinette K Tshefu; Marie A Onyamboko; Tharisara Sakulthaew; Wirichada Pan Ngum; Kamolrat Silamut; Kasia Stepniewska; Charles J Woodrow; Delia Bethell; Bridget Wills; Martina Oneko; Tim E Peto; Lorenz von Seidlein; Nicholas P J Day; Nicholas J White
Journal:  Lancet       Date:  2010-11-07       Impact factor: 79.321

7.  Intravenous artesunate for severe malaria in travelers, Europe.

Authors:  Thomas Zoller; Thomas Junghanss; Annette Kapaun; Ida Gjorup; Joachim Richter; Mats Hugo-Persson; Kristine Mørch; Behruz Foroutan; Norbert Suttorp; Salih Yürek; Holger Flick
Journal:  Emerg Infect Dis       Date:  2011-05       Impact factor: 6.883

8.  Treatment outcome of intravenous artesunate in patients with severe malaria in the Netherlands and Belgium.

Authors:  Annemarie R Kreeftmeijer-Vegter; Perry J van Genderen; Leo G Visser; Wouter F W Bierman; Jan Clerinx; Cees K W van Veldhuizen; Peter J de Vries
Journal:  Malar J       Date:  2012-03-31       Impact factor: 2.979

9.  Published reports of delayed hemolytic anemia after treatment with artesunate for severe malaria--worldwide, 2010-2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-01-11       Impact factor: 17.586

10.  Artesunate versus quinine in the treatment of severe imported malaria: comparative analysis of adverse events focussing on delayed haemolysis.

Authors:  Thierry Rolling; Dominic Wichmann; Stefan Schmiedel; Gerd D Burchard; Stefan Kluge; Jakob P Cramer
Journal:  Malar J       Date:  2013-07-15       Impact factor: 2.979
View more
  4 in total

Review 1.  Malaria 2017: Update on the Clinical Literature and Management.

Authors:  Johanna P Daily
Journal:  Curr Infect Dis Rep       Date:  2017-08       Impact factor: 3.725

2.  When a transfusion in an emergency service is not really urgent: hyperhaemolysis syndrome in a child with sickle cell disease.

Authors:  Sara Chinchilla Langeber; Marta Pilar Osuna Marco; María Benedit; Áurea Cervera Bravo
Journal:  BMJ Case Rep       Date:  2018-03-27

3.  Systematic analysis of direct antiglobulin test results in post-artesunate delayed haemolysis.

Authors:  Tommaso Ascoli Bartoli; Luciana Lepore; Alessandra D'Abramo; Giovanna Adamo; Angela Corpolongo; Laura Scorzolini; Maria Letizia Giancola; Nazario Bevilacqua; Claudia Palazzolo; Andrea Mariano; Giuseppe Ippolito; Pierre Buffet; Emanuele Nicastri
Journal:  Malar J       Date:  2021-04-29       Impact factor: 2.979

4.  Post-artemisinin delayed hemolysis after oral therapy for P. falciparum infection.

Authors:  Christian C Conlon; Anna Stein; Rhonda E Colombo; Christina Schofield
Journal:  IDCases       Date:  2020-03-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.